Related Posts
The CRUCIAL consortium held its second General Assembly on February 10, 2022.
The meeting was held virtually once again, during which all consortium representatives discussed and decided to extend the project’s duration by one year.
The COVID-19 pandemic had a particularly significant impact on CRUCIAL compared to other research projects. This was largely due to the nature of our studies, which involve conditions that increase vulnerability to COVID-19, and because many of the physicians involved were reassigned to patient care during the pandemic.
This project has received funding from the SESAR Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848109.